Monday, 26 October 2026 Newsarchy UK live index
Search LLM RSS
NewsarchyUKUK
Every UK story. Mapped, sourced, and explained where it matters.
BREAKING
Transport Elena Rybakina defends Ningbo title to claim first trophy as world No 1 11:11 Business Elon Musk warns over 200 neoclouds face collapse amid credit squeeze 11:04 Transport Brazil president Lula wins fourth term as challenger Bolsonaro rejects results 10:09 World Jordan arrests three suspects over deadly church shooting in Hamoud 10:05 Culture Eric Bauza, Emmy-Winning Voice Actor, Dies at 46 09:08 Business Melanoma vaccine cuts recurrence and death risk by 42 percent in trial 09:03 Transport Elena Rybakina defends Ningbo title to claim first trophy as world No 1 11:11 Business Elon Musk warns over 200 neoclouds face collapse amid credit squeeze 11:04 Transport Brazil president Lula wins fourth term as challenger Bolsonaro rejects results 10:09 World Jordan arrests three suspects over deadly church shooting in Hamoud 10:05 Culture Eric Bauza, Emmy-Winning Voice Actor, Dies at 46 09:08 Business Melanoma vaccine cuts recurrence and death risk by 42 percent in trial 09:03
Topic

immunotherapy

Melanoma vaccine cuts recurrence and death risk by 42 percent in trial

Melanoma vaccine cuts recurrence and death risk by 42 percent in trial

A bespoke messenger RNA vaccine developed by Moderna and Merck has shown a dramatic reduction in melanoma recurrence when paired with established immunotherapy.

Business ·26 Oct 2026, 09:03 ·Maeve Turner 3 min read